Pandey Suresh K, Cochener Béatrice, Apple David J, Colin Joseph, Werner Liliana, Bougaran Rémi, Trivedi Rupal H, Macky Tamer A, Izak Andrea M
Center for Research on Ocular Therapeutics and Biodevices, Medical University of South Carolina, 167 Ashley Avenue, Charleston, SC 29425, USA.
J Cataract Refract Surg. 2002 Jan;28(1):139-48. doi: 10.1016/s0886-3350(01)01069-0.
To evaluate the efficacy of an intracapsular ring releasing 5-fluorouracil (5-FU) in preventing posterior capsule opacification (PCO) in rabbit eyes.
Center for Research on Ocular Therapeutics and Biodevices, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, USA, and Chu Morvan, Department d'Ophtalmologie, University of Brest, France.
Seventeen rabbits were divided into 3 groups: Group 1, 6 rabbits (6 eyes), had phacoemulsification only (control group); Group 2, 6 rabbits (6 eyes), had phacoemulsification with implantation of an open-loop hydrogel intracapsular ring; Group 3, 5 rabbits (5 eyes), had phacoemulsification with implantation of a ring with sustained release of 0.25 microg/h of 5-FU for 9 days. All eyes were followed for 8 weeks before enucleation. Capsular bag shrinkage and the position of the intracapsular ring were assessed, and central and peripheral PCO was evaluated for intensity and area by stereomicroscopy from a posterior (Miyake-Apple) view. The residual equatorial lens epithelial cells (LECs) were counted by the same observer in histological sections. Transmission electron microscopy (TEM) of the cornea, capsular bag, and retina was done to evaluate the toxicity of 5-FU.
No significant difference was seen in the degree of capsular bag shrinkage in the 3 groups. The intracapsular ring was decentered in 2 eyes (1 each in Groups 2 and 3). There was a statistically significant difference (P <.05, Student t test) between Group 1 and Groups 2 and 3 in the area and intensity of central PCO. There was no difference between Groups 2 and 3 in the intensity of central PCO. No evidence of 5-FU toxicity to intraocular structures (cornea, capsular bag, and retina) was demonstrated on TEM analysis.
Implantation of an intracapsular ring may prevent central PCO after cataract surgery by mechanically blocking LEC migration toward the central visual axis. The potential pharmacological effect of 5-FU in PCO prevention was not demonstrated.
评估囊内环释放5-氟尿嘧啶(5-FU)预防兔眼后囊膜混浊(PCO)的效果。
美国南卡罗来纳州查尔斯顿市南卡罗来纳医科大学风暴眼研究所眼治疗与生物装置研究中心,以及法国布雷斯特大学眼科的楚·莫尔万。
17只兔子分为3组:第1组,6只兔子(6只眼),仅行超声乳化术(对照组);第2组,6只兔子(6只眼),行超声乳化术并植入开环水凝胶囊内环;第3组,5只兔子(5只眼),行超声乳化术并植入可持续释放0.25微克/小时5-FU共9天的环。所有眼睛在摘除前随访8周。评估囊袋收缩情况和囊内环位置,通过后(三宅-苹果)视图的体视显微镜评估中央和周边PCO的强度和面积。由同一名观察者在组织学切片中计数赤道部残留晶状体上皮细胞(LEC)。对角膜、囊袋和视网膜进行透射电子显微镜(TEM)检查以评估5-FU的毒性。
3组囊袋收缩程度无显著差异。囊内环在2只眼中偏心(第2组和第3组各1只)。第1组与第2组和第3组在中央PCO的面积和强度方面存在统计学显著差异(P<.05,学生t检验)。第2组和第3组在中央PCO强度方面无差异。TEM分析未显示5-FU对眼内结构(角膜、囊袋和视网膜)有毒性证据。
植入囊内环可通过机械性阻止LEC向中央视轴迁移来预防白内障手术后的中央PCO。未证实5-FU在预防PCO方面的潜在药理作用。